Sandoz Group AG at its Annual General Meeting held on April 30, 2024, approved that Mathai Mammen, M.D., Ph.D., Graeme Pitkethly and Michael Rechsteiner were elected as new members of the Board of Directors for a term of one year. The following Board members were elected to the Human Capital and ESG Committee for a term of one year: Urs Riedener; Michael Rechsteiner; Aarti Shah, Ph.D.; Ioannis Skoufalos; Maria Varsellona. The Board of Directors intends to redesignate Urs Riedener as chair of the Human Capital and ESG Committee.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.04 CHF | -0.73% | -1.78% | +18.14% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.14% | 15.33B | |
+21.59% | 44.15B | |
+23.03% | 23.02B | |
+12.26% | 13.74B | |
+52.55% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B | |
+7.89% | 4.85B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group AG Announces Board and Committee Appointments